Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.33 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.33 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.33 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.33 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.33 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.33 |
| ▸ | AANAT | Q16613 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20091594 | 0.94 | HPGD (0.33) | HPGDHTTSMN1; SMN2HDAC3HDAC4 | |
| SCHEMBL8735537 | 0.91 | HPGD (0.37) | HPGDHTTSMN1; SMN2HDAC3HDAC4 | |
| SCHEMBL13001926 | 0.90 | HPGD (0.33) | HPGDHTTSMN1; SMN2 | |
| SCHEMBL3705350 | 0.88 | HDAC3 (0.44) | HPGDHTTSMN1; SMN2HDAC3HDAC4 | |
| SCHEMBL16453924 | 0.87 | HPGD (0.38) | HPGDHTTSMN1; SMN2 | |
| SCHEMBL24045358 | 0.87 | HPGD (0.31) | HPGDHTTSMN1; SMN2 | |
| SCHEMBL20091644 | 0.86 | HPGD (0.34) | HPGDHTTSMN1; SMN2 | |
| SCHEMBL1577786 | 0.86 | SMN1; SMN2 (0.37) | HPGDHTTSMN1; SMN2 | |
| SCHEMBL11913384 | 0.86 | SMN1; SMN2 (0.37) | HPGDHTTSMN1; SMN2 | |
| SCHEMBL15669350 | 0.86 | SMN1; SMN2 (0.37) | HPGDHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4322 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235971-A1 | METHODS FOR DETECTING DNA SEQUENCE VARIATION IN THICK TISSUE SECTIONS | THE JOHNS HOPKINS UNIVERSITY (US) | 2025-11-13 | — | — | WO | claimed |
| US-20250295745-A1 | CROSS-LINKED TUMOR LYSATE SPHERICAL NUCLEIC ACIDS AS CANCER VACCINES | NORTHWESTERN UNIVERSITY | 2025-09-25 | — | — | US | claimed |
| EP-4615969-A1 | METHODS FOR DETECTING RNA AND MOLECULAR ANALYSIS IN THICK TISSUE SECTIONS | The Johns Hopkins University (US) | 2025-09-17 | — | — | EP | claimed |
| CN-112533640-B | Targeting of M2-type tumor-associated macrophages using melittin-based apoptosis-inducing peptides | 双亥生命科学株式会社 | 2025-02-28 | — | — | CN | claimed |
| US-12070543-B2 | Blood processing apparatus and method for detoxifying bacterial lipopolysaccharide in vivo | ORTH CONSULTING, LLC (US) | 2024-08-27 | — | — | US | claimed |
| WO-2024103007-A1 | METHODS FOR DETECTING RNA AND MOLECULAR ANALYSIS IN THICK TISSUE SECTIONS | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-05-16 | — | — | WO | claimed |
| US-20230414855-A1 | Blood Processing Apparatus and Method for Detoxifying Bacterial Lipopolysaccharide In Vivo | ORTH CONSULTING, LLC | 2023-12-28 | — | — | US | claimed |
| EP-3362089-B1 | IMMUNOGENIC COMPOSITIONS AGAINST S. AUREUS | SANOFI PASTEUR (FR) | 2023-12-06 | — | — | EP | claimed |
| WO-2023220678-A1 | CROSS-LINKED TUMOR LYSATE SPHERICAL NUCLEIC ACIDS AS CANCER VACCINES | NORTHWESTERN UNIVERSITY (US) | 2023-11-16 | — | — | WO | claimed |
| US-11725222-B2 | Cleavable nucleotide analogs and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-08-15 | — | — | US | claimed |
| WO-2007120579-A2 | LOADED LATEX OPTICAL MOLECULAR IMAGING PROBES | CARESTREAM HEALTH, INC. (US) | 2007-10-25 | — | — | WO | claimed |
| WO-2007046865-A1 | BIOLOGICAL INDICATOR | STERIS, INC. (US) | 2007-04-26 | — | — | WO | claimed |
| EP-1776389-A2 | SIALIC ACID DERIVATIVES | Lipoxen Technologies Limited (GB) | 2007-04-25 | — | — | EP | claimed |
| US-20060269983-A1 | Biological indicator | AMERICAN STERILIZER COMPANY | 2006-11-30 | — | — | US | claimed |
| WO-2006090119-A1 | ACTIVATED SIALIC ACID DERIVATIVES FOR PROTEIN DERIVATISATION AND CONJUGATION | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2006-08-31 | — | — | WO | claimed |
| EP-1689846-A2 | METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES, AND METHODS OF MAKING SAID CONJUGATES | Immunogen, Inc. (US) | 2006-08-16 | — | — | EP | claimed |
| WO-2006016168-A2 | SIALIC ACID DERIVATIVES | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2006-02-16 | — | — | WO | claimed |
| US-20050169933-A1 | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates | IMMUNOGEN, INC. | 2005-08-04 | — | — | US | claimed |
| WO-2005037992-A2 | METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES, AND METHODS OF MAKING SAID CONJUGATES | IMMUNOGEN, INC. (US) | 2005-04-28 | — | — | WO | claimed |
| WO-2004089295-A2 | HOMOGENEOUS AND HETEROGENEOUS ASSAY METHODS USING NUCLEATION CENTERS AND NOVEL COVALENT CHEMISTRIES FOR THE RAPID MEASUREMENT OF PHOSPHORYLATION AND DE-PHOSPHORYLATION | CHROMAGEN, INC. (US) | 2004-10-21 | — | — | WO | claimed |